VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2017

Mar 31, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2017-03-29

Reporting Person: Sachdev Amit (EVP, CRO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-29	Common Stock	M	5719	$38.80	Acquired	105054	Direct
2017-03-29	Common Stock	M	17156	$37.86	Acquired	122210	Direct
2017-03-29	Common Stock	M	29032	$48.74	Acquired	151242	Direct
2017-03-29	Common Stock	M	28593	$45.11	Acquired	179835	Direct
2017-03-29	Common Stock	S	51468	$106.30	Disposed	128367	Direct
2017-03-29	Common Stock	S	29032	$110.00	Disposed	99335	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-29	Stock Option (Right to Buy)	$38.80	M	5719	Disposed	2021-02-02	Common Stock (5719)	Direct
2017-03-29	Stock Option (Right to Buy)	$37.86	M	17156	Disposed	2022-02-01	Common Stock (17156)	Direct
2017-03-29	Stock Option (Right to Buy)	$48.74	M	29032	Disposed	2022-07-24	Common Stock (29032)	Direct
2017-03-29	Stock Option (Right to Buy)	$45.11	M	28593	Disposed	2023-02-04	Common Stock (28593)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	882	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.

F2: Fully vested.